Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Dermatologic 5Thoracic 3Other 2Lymphoid 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Ovarian Neoplasms 3160Uterine Cervical Neoplasms 2182Endometrial Neoplasms 1330Breast Neoplasms 816Fallopian Tube Neoplasms 807Carcinoma, Ovarian Epithelial 771Neoplasms 540Colorectal Neoplasms 437Carcinoma, Non-Small-Cell Lung 418Uterine Cervical Dysplasia 376Pancreatic Neoplasms 363Stomach Neoplasms 353Prostatic Neoplasms 317Lung Neoplasms 315Melanoma 289Uterine Neoplasms 239Peritoneal Neoplasms 238Neoplasm Metastasis 236Vulvar Neoplasms 229Urinary Bladder Neoplasms 225Esophageal Neoplasms 224Head and Neck Neoplasms 221Sarcoma 218Carcinoma, Renal Cell 213Recurrence 212Colonic Neoplasms 210Papillomavirus Infections 205Triple Negative Breast Neoplasms 189Squamous Cell Carcinoma of Head and Neck 175Vaginal Neoplasms 147

Interventions

Loperamide 1Fecal Microbiota Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colitis × Gynecologic × Clear all
NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡